Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Information and Communication Technology-based Centralized Clinical Trial to Determine the Efficacy and Safety of Insulin Dose Adjustment Education Based on a Smartphone Personal Health Record Application

NCT03112343 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT03112343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03112343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Information and Communication Technology-based Centralized Clinical Trial to Determine the Efficacy and Safety of Insulin Dose Adjustment Education Based on a Smartphone Personal Health Record Application
Lead sponsor
Samsung Medical Center
Phase
Not applicable
Overall status
Completed
Start date
September 26, 2017
Completion date
December 30, 2018
Enrollment
112 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, insulin hypoglycemia, insulin-dependent diabetes mellitus